4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-012446
Director acquired 2,672 shares (code L)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krogulski Kenneth Director | 2023-09-05 | Other acquisition 10b5-1 | +325 | $1.71 | $556 | 214,019 | D |
| Krogulski Kenneth Director | 2023-09-06 | Other acquisition 10b5-1 | +325 | $1.68 | $546 | 214,344 | D |
| Krogulski Kenneth Director | 2023-09-07 | Other acquisition 10b5-1 | +325 | $1.71 | $556 | 214,669 | D |
| Krogulski Kenneth Director | 2023-09-08 | Other acquisition 10b5-1 | +325 | $1.71 | $556 | 214,994 | D |
| Krogulski Kenneth Director | 2023-09-11 | Other acquisition 10b5-1 | +325 | $1.74 | $566 | 215,319 | D |
| Krogulski Kenneth Director | 2023-09-12 | Other acquisition 10b5-1 | +325 | $1.79 | $582 | 215,644 | D |
| Krogulski Kenneth Director | 2023-09-13 | Other acquisition 10b5-1 | +325 | $1.86 | $605 | 215,969 | D |
| Krogulski Kenneth Director | 2023-09-14 | Other acquisition 10b5-1 | +325 | $1.87 | $608 | 216,294 | D |
| Krogulski Kenneth Director | 2023-09-15 | Other acquisition 10b5-1 | +72 | $1.82 | $131 | 216,366 | D |
Loading xslF345X05/marketforms-62634.xml…